{"title":"研究设计与分析","authors":"C. Ramers","doi":"10.1093/med/9780190493097.003.0051","DOIUrl":null,"url":null,"abstract":"\n\n\n Upon completion of this chapter, the reader should be able to\n \n\n \n\n\n • Demonstrate basic knowledge regarding the interpretation of results of medical research related to HIV in order to better incorporate emerging scientific concepts into the provision of optimal patient care.\n \n\n \n\n \n\n\n • Differentiate between on-treatment (OT) and intent-to-treat (ITT) analyses and between time-to-loss of virologic response (TLOVR) analysis and a US Food and Drug Administration (FDA) SNAPSHOT analysis....","PeriodicalId":399666,"journal":{"name":"Fundamentals of HIV Medicine 2019","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research Design and Analysis\",\"authors\":\"C. Ramers\",\"doi\":\"10.1093/med/9780190493097.003.0051\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\n\\n Upon completion of this chapter, the reader should be able to\\n \\n\\n \\n\\n\\n • Demonstrate basic knowledge regarding the interpretation of results of medical research related to HIV in order to better incorporate emerging scientific concepts into the provision of optimal patient care.\\n \\n\\n \\n\\n \\n\\n\\n • Differentiate between on-treatment (OT) and intent-to-treat (ITT) analyses and between time-to-loss of virologic response (TLOVR) analysis and a US Food and Drug Administration (FDA) SNAPSHOT analysis....\",\"PeriodicalId\":399666,\"journal\":{\"name\":\"Fundamentals of HIV Medicine 2019\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fundamentals of HIV Medicine 2019\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/med/9780190493097.003.0051\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fundamentals of HIV Medicine 2019","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/med/9780190493097.003.0051","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Upon completion of this chapter, the reader should be able to
• Demonstrate basic knowledge regarding the interpretation of results of medical research related to HIV in order to better incorporate emerging scientific concepts into the provision of optimal patient care.
• Differentiate between on-treatment (OT) and intent-to-treat (ITT) analyses and between time-to-loss of virologic response (TLOVR) analysis and a US Food and Drug Administration (FDA) SNAPSHOT analysis....
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
